We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AbbVie Petitions FDA to Set Clear, Transparent Biosimilar Labeling
AbbVie Petitions FDA to Set Clear, Transparent Biosimilar Labeling
AbbVie filed a citizen petition June 3 urging the FDA to establish clear and transparent labeling requirements for biosimilars, saying this will avoid potentially unsafe substitution of the products and their reference products.